Stocks Health care DYAI
NASDAQ · Health careDyadic International Inc (DYAI)
Dyadic International Inc brought in $3.8M of revenue over the twelve months to June 30, 2026, down 8.0% from a year earlier. It posted a net loss of $7.6M. At June 30, 2026 it held $1.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
Watch DYAI in 60 secondsWhat Dyadic International Inc does
Dyadic International Inc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker DYAI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $3.1M | -$7.4M | -$0.23 | n/a |
| 2024 | $3.5M | -$5.8M | -$0.20 | n/a |
| 2023 | $2.9M | -$6.8M | -$0.24 | n/a |
| 2022 | $2.9M | -$9.7M | -$0.34 | n/a |
| 2021 | $2.4M | -$13.1M | -$0.47 | n/a |
| 2020 | $1.6M | -$9.3M | -$0.34 | n/a |
Full financial statements: income, balance sheet and cash flow
Where DYAI ranks in Health care
Latest SEC filings
What Dyadic International Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 25, 2026
- September 18, 2026
- September 11, 2026IPO registration S-1
- August 17, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026
- August 13, 2026
- August 12, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 0.6% to $961.1K versus the same quarter last year; diluted EPS -$0.06 versus -$0.06.
- August 12, 2026
- July 24, 2026Other event 8-K
- July 6, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running Dyadic International Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $125K worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 24, 2026 | Francisco Trust under agreement dated February 28, 199610% owner | Sold | 2,616 | $3.2K |
| July 23, 2026 | Francisco Trust under agreement dated February 28, 199610% owner | Sold | 54,760 | $71.3K |
| July 22, 2026 | Francisco Trust under agreement dated February 28, 199610% owner | Sold | 38,016 | $50.5K |
Who owns DYAI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Mark A. Emalfarb13G, passive | 17.5% | February 17, 2026 |
| Francisco Trust under agreement dated February 28, 199613G, passive | 10.32% | August 17, 2026 |
Largest institutional holders
Insiders
1 insiders reported holding 3,280,272 shares in total, about $1.4M at the last price.
| Holder | Shares |
|---|---|
| Francisco Trust under agreement dated February 28, 199610% owner | 3,280,272 |
Questions about DYAI
What does Dyadic International Inc do?
Dyadic International Inc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker DYAI.
Is Dyadic International Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $7.6M on revenue of $3.8M.
How much revenue does Dyadic International Inc make?
Over the twelve months to June 30, 2026 Dyadic International Inc reported revenue of $3.8M. That is 8.0% less than a year earlier.
When did Dyadic International Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the stock exchange listing notice from September 25, 2026.
Similar companies
Compare DYAI with
Follow DYAI
Get an email when Dyadic International Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow DYAI: get an email when it filesWhere the numbers come from
Financial figures are the values Dyadic International Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.